Send feedback

SUN2 p.Arg387His

c.1160G>A · rs775651955 · VCV1497434

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.0796 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00134%, afr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
Emery-Dreifuss muscular dystrophy

⚠ Built without this gene's context — gene constraint and dosage, protein structure, pathways, panels and related-variant links were not looked up for this page. why

Computational evidence

Protein change
AlphaMissense0.0796likely benign
REVEL0.028moderately benign-leaning
SaProtLLR -8.63tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not looked up on this page · why
Constraint at this position
ConservationphyloP -2.5GERP -3.7
Regional constrainto/e 0.94unconstrained · MANE · 12 kb · p 0.11 · regional, not allelic
Overall
CADD14.36PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00134% African / African-American · 1/74,596 alleles
Filtering AF 0.000294% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000212%
Overall 0.00426% 68/1,597,120 alleles · very rare exomes 56/1,445,038 · genomes 12/152,082 · joint denominator
Ancestry group Frequency 1 in
Finnishnot grpmax-eligible 0.0943% 1,060
African / African-Americangrpmax 0.00134% 74,596
European (non-Finnish) 0.000683% 146,470

Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SUN2
Protein
p.Arg387His
Coding
c.1160G>A
MANE Select
NM_015374
dbSNP
rs775651955
Type
single nucleotide variant
Location
chr22:38741037 (GRCh38)
Full SUN2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Emery-Dreifuss muscular dystrophy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Emery-Dreifuss muscular dystrophy (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, X-linked recessive
Onset
Childhood
Prevalence
1-9 / 1 000 000 (Europe)

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sun2-p-arg387his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown